Health
Study shows lower antibody cross-reactivity after infection with the B.1.1.7 SARS-CoV-2 variant – News-Medical.Net
In a recent research paper currently available on the bioRxiv* preprint server, a diverse group of researchers has examined the immunogenicity of antibodies against…
In a recent research paper currently available on the bioRxiv* preprint server, a diverse group of researchers has examined the immunogenicity of antibodies against the variant B.1.1.7 of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) initially found in the United Kingdom – and revealed diminished recognition and neutralization of either parental strains or the South African variant.
The ceaseless pandemic of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 still has a…
-
Noosa News17 hours agoTallest tower outside CBD approved for construction at 205 metres
-
Noosa News5 hours agoJessica Alba spotted filming spy thriller on the Gold Coast as cameras roll under iconic bridge
-
Noosa News22 hours agoTrucking company penalised for refusing to pay unfairly sacked worker
-
Noosa News18 hours agoFarmgate Backpackers leads with integrity amid industry challenges